IP Library › Assignment 066821/0809
Patent Assignment
Reel/Frame 066821/0809

Change of Name

Recorded: 2024-03-19 Pages: 31
Assignor
ARCUTIS, INC.
Executed: 2019-10-08
Assignee
ARCUTIS BIOTHERAPEUTICS, INC.
3027 TOWNSGATE ROAD, #300, WESTLAKE VILLAGE, CALIFORNIA, 91361
Covered Properties (3)
Topical Roflumilast Formulation Having Improved Delivery and Plasma Half Life
Application: 17/402,051 →
Publication: US 2021/0386719
Topical Roflumilast Formulation Having Improved Delivery and Plasma Half- Life
Application: 18/176,601 →
Publication: US 2023/0310397
Topical Roflumilast Formulation Having Improved Delivery and Plasma Half- Life
Application: 18/353,869 →
Publication: US 2023/0364066
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Dec 22, 2021
From: ARCUTIS BIOTHERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 058463/0187 →
Assignment of Assignor's Interest Mar 19, 2024
From: OSBORNE, DAVID W.
To: ARCUTIS, INC.
Reel/Frame 066821/0437 →
Security Interest Aug 9, 2024
From: ARCUTIS BIOTHERAPEUTICS, INC.
To: SLR INVESTMENT CORP.
Reel/Frame 068236/0418 →